These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15767639)

  • 21. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
    Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
    Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
    Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
    J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
    Klerk CP; Smorenburg SM; Büller HR
    Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US.
    Luciani A; Clement O; Halimi P; Goudot D; Portier F; Bassot V; Luciani JA; Avan P; Frija G; Bonfils P
    Radiology; 2001 Sep; 220(3):655-60. PubMed ID: 11526263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.
    Niers TM; Di Nisio M; Klerk CP; Baarslag HJ; Büller HR; Biemond BJ
    J Thromb Haemost; 2007 Sep; 5(9):1878-82. PubMed ID: 17723127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.
    Boraks P; Seale J; Price J; Bass G; Ethell M; Keeling D; Mahendra P; Baglin T; Marcus R
    Br J Haematol; 1998 Jun; 101(3):483-6. PubMed ID: 9633891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of catheter-related venous thrombosis in cancer patients.
    Karthaus M
    Support Care Cancer; 2008 Jul; 16(7):787-90. PubMed ID: 18274788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters.
    Schoot RA; van de Wetering MD; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Zwaan M; Lieverst JA; Caron HN; van Ommen H;
    Pediatr Blood Cancer; 2016 Aug; 63(8):1438-44. PubMed ID: 27128820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
    Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis prophylaxis in cancer patients with a central venous catheter.
    Laporte S; Decousus H; Mismetti P
    Arch Intern Med; 2004 Feb; 164(4):459; author reply 459-60. PubMed ID: 14980999
    [No Abstract]   [Full Text] [Related]  

  • 32. Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit.
    Malinoski D; Ewing T; Bhakta A; Schutz R; Imayanagita B; Casas T; Woo N; Margulies D; Barrios C; Lekawa M; Chung R; Bukur M; Kong A
    J Trauma Acute Care Surg; 2013 Feb; 74(2):454-60; discussion 461-2. PubMed ID: 23354238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters.
    Mokrzycki MH; Jean-Jerome K; Rush H; Zdunek MP; Rosenberg SO
    Kidney Int; 2001 May; 59(5):1935-42. PubMed ID: 11318966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin.
    Diamond CE; Hennessey C; Meldau J; Guelcher CJ; Guerrera MF; Conklin LS; Sharma KV; Diab YA
    J Pediatr; 2018 Jul; 198():53-59. PubMed ID: 29628414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.
    Fagnani D; Franchi R; Porta C; Pugliese P; Borgonovo K; Bertolini A; Duro M; Ardizzoia A; Filipazzi V; Isa L; Vergani C; Milani M; Cimminiello C;
    Ann Oncol; 2007 Mar; 18(3):551-5. PubMed ID: 17158773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Clinical Trial of Low-dose Warfarin Therapy for Improving the Longevity of Permanent Arteriovenous Catheters.
    Saroukhani A; Nasab MG
    Ann Vasc Surg; 2021 May; 73():165-170. PubMed ID: 33373763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.
    Wilkieson TJ; Ingram AJ; Crowther MA; Soroka SD; Nagai R; Jindal KK; Clase CM
    Clin J Am Soc Nephrol; 2011 May; 6(5):1018-24. PubMed ID: 21493739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.